Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma
- PMID: 35945149
- DOI: 10.1016/j.jasc.2022.07.003
Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma
Abstract
Introduction: Serous effusion is often the first sign of mesothelioma. Diagnosis based on cytologic material from the effusions remains controversial and complementary biopsy is usually required. However, obtaining representative tissue sample may be challenging, while obtaining cytologic material is a minimally invasive procedure, providing potential for an earlier diagnosis. Loss of BRCA1-associated protein (BAP1), combined with loss of methylthionadenosine phosphorylase (MTAP) detected by immunohistochemistry, have shown to be reliable markers in the diagnosis of mesothelioma on histologic sections. Here we evaluate the value of these biomarkers in cytologic specimens.
Materials and methods: The BAP1 and MTAP expression in specimens of 162 mesothelioma patients (156 pleural, 6 peritoneal)-71 cytologic, 91 histologic (44 epithelioid, 31 biphasic, 16 sarcomatoid)-and 20 patients with reactive mesothelial proliferations were investigated.
Results: The loss of BAP1 and/or MTAP was highly sensitive and specific in differentiating mesothelioma from reactive mesothelial proliferations, with no significant difference between pleural effusions and biopsies, specificity of 100% in both and a sensitivity of 78.9% and 80.2%, respectively (P = 0.3). There was a 100% concordance of the expression of BAP1 and MTAP in cytologic and corresponding histopathologic samples. Loss of BAP1 and/or MTAP in histologic sections discriminated sarcomatoid, biphasic, and epithelioid mesothelioma from reactive mesothelial proliferations with a sensitivity of 81.2%, 83.9%, and 77.3% respectively.
Conclusion: Loss of expression of BAP1 and/or MTAP differentiated mesothelioma from reactive mesothelial proliferations with excellent specificity and high sensitivity in cytologic samples, comparable to histopathologic sections.
Keywords: BRCA1-Associated protein (BAP1); Effusion cytology; Immunohistochemistry; Mesothelioma; Methylthionadenosine phosphorylase (MTAP).
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.Cancer Cytopathol. 2020 Feb;128(2):126-132. doi: 10.1002/cncy.22221. Epub 2019 Dec 10. Cancer Cytopathol. 2020. PMID: 31821740
-
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.Lung Cancer. 2018 Nov;125:198-204. doi: 10.1016/j.lungcan.2018.09.019. Epub 2018 Sep 26. Lung Cancer. 2018. PMID: 30429020
-
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.Cancer Cytopathol. 2018 Jan;126(1):54-63. doi: 10.1002/cncy.21928. Epub 2017 Oct 20. Cancer Cytopathol. 2018. PMID: 29053210
-
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.Pathology. 2024 Aug;56(5):662-670. doi: 10.1016/j.pathol.2024.02.016. Epub 2024 May 9. Pathology. 2024. PMID: 38789301 Review.
-
Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations.Pathol Int. 2022 Aug;72(8):389-401. doi: 10.1111/pin.13235. Epub 2022 May 21. Pathol Int. 2022. PMID: 35596704 Review.
Cited by
-
Primary Peritoneal Mesothelioma Affecting the Greater Omentum That Mimicked an Omental Infarction: A Case Report.Case Rep Oncol. 2024 May 30;17(1):596-601. doi: 10.1159/000538991. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 39015649 Free PMC article.
-
Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive Series.Cancers (Basel). 2023 Nov 22;15(23):5534. doi: 10.3390/cancers15235534. Cancers (Basel). 2023. PMID: 38067238 Free PMC article.
-
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities.Diagnostics (Basel). 2025 May 24;15(11):1323. doi: 10.3390/diagnostics15111323. Diagnostics (Basel). 2025. PMID: 40506895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous